Country: Canada
Language: English
Source: Health Canada
DICLOFENAC SODIUM
APOTEX INC
S01BC03
DICLOFENAC
0.1%
SOLUTION
DICLOFENAC SODIUM 0.1%
OPHTHALMIC
2.5/5/10ML FILL
Prescription
NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0114417004; AHFS:
APPROVED
2015-05-12
_APO-DICLOFENAC OPHTHALMIC (Diclofenac Sodium Ophthalmic Solution)_ _Page 1 of 28_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR APO-DICLOFENAC OPHTHALMIC Diclofenac Sodium Ophthalmic Solution Ophthalmic solution, 0.1% w/v for Topical use Anti-inflammatory agents, non-steroids APOTEX INC. 150 Signet Drive Toronto, Ontario M9L 1T9 Date of Initial Authorization: MAY 12, 2015 Date of Revision: SEP 18, 2023 Submission Control Number: 275184 _APO-DICLOFENAC OPHTHALMIC (Diclofenac Sodium Ophthalmic Solution)_ _Page 2 of 28_ RECENT MAJOR LABEL CHANGES 7 WARNINGS AND PRECAUTIONS, Reproductive Health: Female and Male Potential 09/2023 7 WARNINGS AND PRECAUTIONS, 7.1.1 Pregnant Women 09/2023 TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES ............................................................................................ 2 TABLE OF CONTENTS ........................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION ...................................................................... 4 1 INDICATIONS ........................................................................................................... 4 1.1 Pediatrics ........................................................................................................... 4 1.2 Geriatrics ........................................................................................................... 4 2 CONTRAINDICATIONS .................................................................................................. 4 4 DOSAGE AND ADMINISTRATION ................................................................................. 4 4.2 Recommended Dose and Dosage Adjustment ................................................... 4 4.4 Administration ................................................................................................... 5 4.5 Missed Dose .......................... Read the complete document